NAFLD and Cardiometabolic Risk Factors: The Liver Fibrosis Trajectory Through the Lens of Biological Interactions

被引：3
|
作者：
Pirola, Carlos J. [1 ,2 ]
Sookoian, Silvia [1 ,3 ]
机构：
[1] Univ Buenos Aires, Fac Med, Inst Invest Med A Lanari, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn CONICET, Dept Genet & Biol Mol Enfermedades Complejas, Inst Invest Med IDIM, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn CONICET, Dept Hepatol Clin & Mol, Inst Invest Med IDIM, Buenos Aires, DF, Argentina
来源：
HEPATOLOGY | 2021年 / 73卷 / 02期
关键词：
D O I：
10.1002/hep.31672
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：479 / 482
页数：4
相关论文
共 50 条
  • [1] Cardiometabolic Risk Factors Superior to FIB4 in Identifying Adults at Risk for NAFLD with Fibrosis
    Leiva, Eddison Godinez
    Sharma, Anu
    Kalavalapalli, Srilaxmi
    Rocha, Andrea Ortiz
    Saenz, Enrique Valdez
    Mohseni, Yasmine
    Pardo, Nathaly Cuervo
    Rosenberg, Jens T.
    Grajo, Joseph R.
    Barb, Diana
    Cusi, Kenneth
    DIABETES, 2024, 73
  • [2] MEASURES OF CARDIOMETABOLIC RISK AND ADVANCED FIBROSIS IN PRIMARY CARE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Schreiner, Andrew
    HEPATOLOGY, 2023, 78 : S1004 - S1004
  • [3] Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial
    Shirazi, Kourosh Masnadi
    Shirinpour, Elham
    Shirazi, Arman Masnadi
    Nikniaz, Zeinab
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2021, 21 (01)
  • [4] Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial
    Kourosh Masnadi Shirazi
    Elham Shirinpour
    Arman Masnadi Shirazi
    Zeinab Nikniaz
    BMC Complementary Medicine and Therapies, 21
  • [5] Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Ramanakumar, Agnihotram V.
    Cinque, Felice
    Ballestreros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Phil
    Chen, Tianyan
    Kronfli, Nadine
    Saeed, Sahar
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    JOURNAL OF VIRAL HEPATITIS, 2025, 32 (02)
  • [6] Individuals with cardiometabolic risk factors are at higher risk for early-onset NAFLD
    He, Linfeng
    Zheng, Wenbin
    Liao, Yunfei
    Kong, Wen
    Zeng, Tianshu
    JOURNAL OF HEPATOLOGY, 2024, 81 (03) : e99 - e101
  • [7] Cardiovascular risk factors are independent of fibrosis severity in NAFLD
    Roccarina, D.
    Buzzetti, E.
    Misas, M. G.
    Rosselli, M.
    Majumdar, A.
    Pinzani, M.
    Tsochatzis, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S154 - S154
  • [8] Cardiovascular risk factors and fibrosis severity in NAFLD: is there a link?
    Roccarina, Davide
    Prat, Laura Iogna
    Guerrero, Marta
    Buzzetti, Elena
    Mantovani, Anna
    Goyale, Atul
    Arico', Francesco
    Saffioti, Francesca
    Pinzani, Massimo
    Tsochatzis, Emmanuel
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E308 - E308
  • [9] The effects of obesity phenotypes on NAFLD and related cardiometabolic risk factors in children
    Meng, Linghui
    Mi, Jie
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 : S117 - S117
  • [10] Prevalence of NAFLD and risk factors associated with liver fibrosis in a cohort of people with HIV in Barcelona (Spain)
    Laguno, M.
    Berrocal, L.
    De lazzari, E.
    Inciarte, A.
    Ambrosioni, J.
    Torres, B.
    Martinez-Rebollar, M.
    Gonzalez-Cordon, A.
    De la Mora, L.
    Chivite, I.
    Foncillas, A.
    Blanco, J. L.
    Miro, J. M.
    Martinez, E.
    Mallolas, J.
    HIV MEDICINE, 2023, 24 : 644 - 644
12345